aspsirna0265 details

Purple = Wild vs mutant target sequence along with mutation information
Brown= Wild vs ASP-siRNA description along with positional differnece between two
Light pink= ASP siRNA efficacy for mutant vs wild allele
Green= Wild siRNA efficacy for Wild vs Mutant allele
siRNA Id:aspsirna0265
siRNA Name: LRRK2 P11_9A
Gene:Leucine rich repeat kinase 2 (LRRK2) Gene
Disease:Parkinsons disease (PD)
Wild allele/target (5'->3'): CUGACUACGGCAUUGCUCA
Mutant allele/target (5'->3'):CUGACUACAGUAUUGCUCA
Target Mutation: c.6055G>A,p.Gly2019Ser
Wild siRNA (As strand):GACUGAUGCCGUAACGAGU
ASP-siRNA (As strand):GACUGAUGUCAUAACGAGU
Mismatch position in siRNA: U11C,A9G
Mutant allele (5'->3'): CUGACUACAGUAUUGCUCA
ASP-siRNA (As strand):GACUGAUGUCAUAACGAGU
ASP-siRNA efficacy for mutant allele:72
Wild allele (5'->3'): CUGACUACGGCAUUGCUCA
ASP-siRNA (As strand):GACUGAUGUCAUAACGAGU
ASP-siRNA efficacy for wild allele:60
Percentage discrimination for ASP-siRNA:12
Wild allele (5'->3'): CUGACUACGGCAUUGCUCA
Wild siRNA (As strand):GACUGAUGCCGUAACGAGU
Wild sirna efficacy for wild allele:High efficacy
Wild allele (5'->3'): CUGACUACGGCAUUGCUCA
ASP-siRNA (As strand):GACUGAUGUCAUAACGAGU
Wild sirna efficacy for mutant allele:Moderate efficacy
Percentage discrimination for wild siRNA:Poor discrimination
Concentration:50nM
Orientation:Sense
Mismatch in:siRNA
UniProt ID: Q5S007
Target sequence: UUGCAAAGAUUGCUGACUACGGCAUUGCUCAGUACUGC
Genbank Accesion: NM_198578.3
Cell-line: HEK293
Experimental technique used: Flourescence microscopy
Transfection method: Lipofectamine 2000
siRNA expression method: Sigma Genosys
Post-transfection duration: 48 hours
OMID ID: 168600
KEGG disease ID:H00057
Reference:22031823

.
.
.
.
.
.
.
.
.
.
.

.

.

.